The bill amends the Code of West Virginia to expand the scope of practice for licensed pharmacists. It authorizes pharmacists to prescribe certain non-controlled drugs in accordance with FDA-approved labeling, specifically for conditions that can be tested using waived laboratory tests, such as influenza, SARS-COV-2, and RSV. Additionally, pharmacists are permitted to refill expired prescriptions for epinephrine injection devices. The bill mandates that pharmacists notify the patient's primary care physician within 72 hours of the test results and the prescribed medication. Furthermore, any prescription issued under this new provision is limited to a 30-day supply within a six-month period, with additional notification requirements if more than 10 days is prescribed.

The legislation also includes provisions for pharmacists to administer immunizations, provided they meet specific requirements set by legislative rule. It maintains existing regulations regarding the sale of potentially harmful medicines, ensuring that only registered pharmacists can sell such products while informing purchasers of their nature. Overall, the bill aims to enhance patient care by allowing pharmacists to take a more active role in medication management and patient health monitoring.

Statutes affected:
Introduced Version: 30-5A-1, 30-5A-2, 30-5A-3
Committee Substitute: 30-5A-1, 30-5A-2, 30-5A-3, 30-5A-4
Engrossed Committee Substitute: 30-5A-1, 30-5A-2, 30-5A-3, 30-5A-4
Enrolled Committee Substitute: 30-5-10